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In December 2019, an epidemic of pneumonia cases of unknown origin emerged in Wuhan, Hubei Province, China (adhikari et al., 2020; yeo, Kaushal, & yeo, 2020; Zhu et al., 2020). 
This acute respiratory syndrome is now known to be 
caused by severe acute respiratory syndrome coro-
navirus 2 (SaRS-CoV-2) (Gorbalenya et al., 2020). 
according to a World Health Organization (WHO) 
report, as of June 27, 2020, it has infected near 10 
million individuals globally, with around 500,000 
deaths (WHO, 2020a). The WHO has recently 
declared COVID-19 a global emergency of interna-
tional concern (Sohrabi et al., 2020). Similar to 
other coronaviruses, person-to-person transmission 
of COVID-19 pneumonia occurs primarily through 
close contact with an infected patient, mainly via 
respiratory droplets and after touching contaminat-
ed objects (Ghinai et al., 2020; WHO, 2020b; yu, 
Zhu, Zhang, & Han, 2020). Therefore, effective 
infection control measures, including patient 
isolation, are critical for decreasing the infection 
incidence rate.
Clinical Manifestations of Gastrointestinal 
Symptoms in COVID-19 Patients
An Integrative Review
ABSTRACT
After the outbreak of novel coronavirus disease 2019 (COVID-19) in Wuhan, China, its spread to other countries is 
rapidly increasing. In this integrative review, we report the prevalence of gastrointestinal symptoms in patients with 
COVID-19. For this purpose, available articles on gastrointestinal manifestations in patients with COVID-19, which 
were reported from China, were reviewed. All reviewed articles were searched from December 11, 2019, to June 20, 
2020, based on specific key words. Related findings in these articles show that the main target of COVID-19 is lung 
tissue, as after the virus enters the body, it mainly causes respiratory symptoms in affected patients. But in addition 
to respiratory symptoms, it is possible that, over time, these patients present with other symptoms, the most obvi-
ous of which are gastrointestinal symptoms. It is well documented that diarrhea and vomiting are the most common 
gastrointestinal symptoms in COVID-19 patients. As part of this report, we also look at the incidence and frequency of 
gastrointestinal symptoms in COVID-19 patients in Iran. The results can be used by providers as a guideline for bet-
ter management of gastrointestinal symptoms in these patients.
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Background
Several studies have reported the clinical characteris-
tics of patients with COVID-19 (Chang et al., 2020; 
Guan et al., 2020). For better management of the dis-
ease, recognition of clinical characteristics of COVID-
19 can be helpful for clinicians to make proper deci-
sions. One of the complications of this disease in a 
large group of patients is gastrointestinal (GI) disor-
ders, although not common (Zarifian et al., 2020). In 
most studies, it has been reported that patients with 
COVID-19 have GI symptoms, mainly including diar-
rhea, nausea, and anorexia, in addition to common 
respiratory symptoms (an et al., 2020; Chen, Qi, 
et al., 2020; Meng et al., 2020; Zarifian et al., 2020).
Studies of the COVID-19 pathogenic mechanism 
have shown that the virus enters the target cell 
through angiotensin-converting enzyme-2 (aCE-2) 
(Hoffmann et al., 2020). This enzyme has been shown 
to play a major role in the cleaving of several peptides 
interfering in the renin–angiotensin pathway. Because 
the expression of this enzyme in the epithelial cells of 
the lung, intestine, kidney, and blood vessels is at its 
highest level, it is not unreasonable to expect that the 
main target of this virus is the organs that have a high 
expression of this enzyme (Harmer, Gilbert, Borman, 
& Clark, 2002). Lung tissue is one of these organs 
that have a high overexpression of aCE-2 receptors. 
although GI manifestations may be less common in 
some patients, it may be considered the initial sign of 
infection with SaRS-CoV-2 (Gao, Chen, & Fang, 
2020; Gu, Han, & Wang, 2020). However, studies of 
these complications have reported a different preva-
lence for some GI symptoms such as diarrhea (Liang 
et al., 2020).
Methods
Inclusion and Exclusion Criteria
We included available data on COVID-19 patients 
confirmed in case reports and retrospective clinical 
studies relating to the GI presentations in hospitalized 
patients from China that were published in English 
between December 11, 2019, and June 20, 2020. 
Studies that did not discuss GI presentations were 
excluded.
Literature Search
Data for this review article were searched in the pub-
lished and unpublished preprint articles up to June 
20, 2020, in the PubMed, Scopus, and Google Scholar 
databases. We performed extensive hand searching of 
reference lists of articles and reports. The search 
terms used were “SaRS-CoV-2” and “COVID-19” 
combined with “gastrointestinal,” “clinical charac-
teristics,” or “digestive.” We identified 28 articles 
from the initial search that met inclusion and exclu-
sion criteria based on title and abstract. Of these, 11 
were duplicates, resulting in 17 studies included for 
analysis (Table 1).
Data Extraction
We reviewed the 17 eligible Chinese studies and 
extracted data for province or city, patient age group 
range and gender, study size, severity of illness, and 
symptom categories. When extracting information 
from the studies, pairs of researchers conferred to com-
pare findings and reach consensus. Where consensus 
was not reached, an independent researcher was 
consulted.
Literature Review
Wang, Fang, et al. (2020) aimed to study the clinical 
characteristics of noncritical COVID-19 patients who 
were admitted to Dongxihu Fangcang Hospital, China, 
between February 7 and 12, 2020. among 1,012 non-
critically ill individuals, fever (761 of 1,012; 75.2%) 
and cough (531 of 1,012; 52.4%) were the most com-
mon clinical symptoms. along with these symptoms, 
the patients presented some GI symptoms including 
diarrhea, vomiting, and abdominal pain. Diarrhea was 
the main GI symptom in 152 patients (15%). abdominal 
pain (37 of 1,012; 3.7%) and vomiting (36 of 1,012; 
3.6%) were the other GI symptoms occurring in these 
patients. The high incidence rate for diarrhea compared 
with similar studies can be considered as one of the 
main outcomes of the study. In some published studies, 
the incidence of diarrhea in patients with COVID-19 
ranged from 2% to 10% (Guan et al., 2020; Liu et al., 
2020; Wang, Fang, et al., 2020; Xu, Wu, et al., 2020). 
The authors explained that the use of some drugs such 
as arbidol and moxifloxacin before admission to 
Fangcang Hospital may be attributed to this high inci-
dence of diarrhea. The research group mentioned that 
diarrhea, although with a low incidence, should not be 
ignored in patients with COVID-19, indicating the pos-
sibility of fecal–oral transmission. The authors 
expressed that the severity of the GI symptoms was 
associated with gender, age, and a history of diabetes 
and cardiovascular diseases.
Guan et al. (2020) described the results of the clinical 
characteristics of COVID-19 in a selected cohort of 
patients throughout China. In 1,099 enrolled patients in 
their study, fever (43.8% on admission and 88.7% dur-
ing hospitalization) and cough (48.2%) were the most 
common presenting symptoms (Table 1). However, 
diarrhea (3.8%) and nausea or vomiting (5.0%) were 
the second most common symptoms in these patients. 
Some patients had high aspartate aminotransferase 
(aST) levels (>40 U/L; 22.2%), others had high alanine 
aminotransferase (aLT) levels (>40 U/L; 21.3%), and 
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some had high total bilirubin levels (>17.1 μmol/L; 
10.5%). Findings of this research group demonstrated 
that patients with more severe conditions showed a 
higher incidence of diarrhea, as well as higher aST and 
aLT levels, in comparison with patients with mild con-
ditions (5.8% vs. 3.5% for diarrhea; 28.1% vs. 19.8% 
for aLT level; 39.4% vs. 18.2% for aST level; and 
13.3% vs. 9.9% for total bilirubin).
Chen, Zhou, et al. (2020) investigated 99 patients 
with confirmed cases of 2019 novel coronavirus 
(2019-nCoV) in Wuhan Jinyintan Hospital, China, 
from January 1 to 20, 2020. Their study revealed that 
fever (83%), cough (82%), and dyspnea (31%) were 
the main symptoms in these patients. also, diarrhea 
(2%) and nausea and vomiting (1%) were the main 
presenting GI disorders in the patients.
The epidemiology and initial clinical characteristics 
of confirmed cases of COVID-19 from January 20 to 
February 6, 2020, were investigated in Shanghai, 
China, by Chen, Qi, et al. (2020). The majority of 
COVID-19 cases were mild, and a total of 215 (86.3%) 
patients were discharged after hospitalization. Fever (n 
= 235; 94.3%), cough (n = 91; 36.5%), and fatigue (n 
= 39; 15.7%) were the main symptoms in these 
patients. Diarrhea (n = 8; 3.2%) and loss of appetite 
(n = 8; 3.2%) were the only GI disorders in these 
patients. Elevated levels of aLT and aST were also less 
common in this sample. The researchers found that 
gender, age, higher levels of white blood cells, as well 
as C-reactive protein (CRP) and lactate dehydrogenase 
(LDH), and low levels of albumin could have a signifi-
cant effect on the severity of symptoms in hospitalized 
patients in the intensive care unit (ICU).
Li et al. (2020) evaluated the relationship between 
risk factors and mortality rate in adult COVID-19 
patients admitted to Tongji Hospital, China, from 
January 26 to February 5, 2020. They retrospectively 
enrolled 548 patients (279 patients with severe symp-
toms and 269 with mild symptoms) in the study and 
analyzed the findings, as well as followed up until 
March 3, 2020. The main symptoms in patients were 
fever (95.2%), fatigue (47.1%), cough (75.7%), and 
dyspnea (56.6%). Patients with both severe and mild 
symptoms showed an almost equal number of GI dis-
orders including vomiting (9% vs. 7.4%) and diarrhea 
(33.7% vs. 31.6%). However, the number of patients 
with severe conditions presented severe abdominal 
pain (4.5% vs. 1.4%) as well as hypoalbuminemia 
(72.9% vs. 45.8%) and higher levels of total bilirubin 
(12.6% vs. 6.3%) than those with mild symptoms. 
High levels of albumin (<35 g/L), aLT (>40 U/L), and 
aST (>40 U/L) were seen in both patient groups with 
nonsevere and severe conditions reported as 45.8% 
versus 72.9%, 22.3% versus 24.1%, and 23.3% ver-
sus 43.4%, respectively.
Meng et al. (2020) aimed to characterize computed 
tomographic (CT) scan and the clinical course of 58 
asymptomatic cases that developed COVID-19 pneu-
monia retrospectively in patients admitted to the 
Renmin Hospital, China, between January 1 and 
February 23, 2020. On admission, patients without 
any clinical symptoms associated with COVID-19 but 
who had a history of exposure to SaRS-CoV-2 were 
confirmed by SaRS-CoV-2 nucleic acid testing and CT 
scan. These patients were then followed every 3–7 
days. Of these, 16 presented with symptoms of low 
lymphocyte count and high CRP including fever (n = 
8 cases; 50%), cough (n = 9 cases; 56.3%), fatigue (n 
= 8 cases; 50%), shortness of breath (n = 2 cases; 
12.5%), and diarrhea (n = 1 case; 6.3%) (Table 1). 
The authors emphasized the importance of surveillance 
for COVID-19 in asymptomatic patients with known 
exposure (Meng et al., 2020).
Zhang et al. (2020) investigated the clinical charac-
teristics of COVID-19-infected cancer patients (n = 
28) admitted to three designated hospitals in Wuhan, 
China, for quarantine and treatment of COVID-19 
from January 13 to February 26, 2020. among the 28 
patients enrolled, lung cancer was the most frequent 
type of cancer (n = 7; 25.0%). The most common 
symptoms on admission were fever (n = 23; 82.1%), 
dry cough (n = 22; 81%), fatigue (n = 18; 64.3%), 
and dyspnea (n = 14; 50.0%). Diarrhea (n = 3; 
10.7%) was the main GI disorder reported.
He et al. (2020) explored the clinical course and 
dynamic features of immune status in COVID-19 
patients at Renmin Hospital of Wuhan, China, between 
January 10 and February 13, 2020. This research 
group aimed to find predictors correlated with severity 
and prognosis of COVID-19. They collected and ana-
lyzed the electronic medical records of 204 patients 
with COVID-19 pneumonia (nonsevere: n = 135; and 
severe: n = 69) confirmed by nucleic acid testing, ret-
rospectively. Fever (n = 146; 71.5%) and cough (n = 
84; 41.1%) were the main presenting symptoms in the 
patients. Some patients complained of diarrhea (n = 
19; 9.31%) and anorexia (n = 12; 5.8%) with the 
same severity between patients diagnosed with severe 
and nonsevere COVID-19 conditions (7.2% vs. 10.3% 
for diarrhea and 7.2% vs. 5.1% for anorexia).
Wu et al. (2020) retrospectively and consecutively 
investigated the clinical and laboratory characteristics 
of COVID-19 confirmed cases at hospitals in Jiangsu, 
China, from January 22 to February 14, 2020. 
according to their findings, fever (n = 63; 78.7%) and 
cough (n = 51; 63.7%) were the main symptoms in 
these patients. No patients had hemoptysis or diarrhea 
symptoms. Only three patients (3.75%) presented with 
liver function disorders including elevated aLT or aST 
levels above the normal range.
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Liu et al. (2020) conducted a retrospective analysis 
involving hospitalized children in Wuhan, China, from 
January 7 to January 15, 2020. a total of 366 hospital-
ized children (≤16 years of age) were enrolled in the 
study. High fever (>102.2 °F) and cough were the 
common clinical characteristics. Vomiting was the 
main GI symptom presenting in four cases.
yang, Cao, et al. (2020) investigated the clinical 
characteristics and imaging manifestations of hospital-
ized patients with confirmed COVID-19 infection from 
January 17 to February 10, 2020, in three tertiary hos-
pitals of Wenzhou City, China. among 149 real-time 
reverse transcription–polymerase chain reaction (rRT-
PCR)-confirmed positive patients, fever (n = 114; 
76.5%) and cough (n = 87; 58.3%) were the main 
presenting symptoms in these patients. Some patients 
complained of diarrhea (n = 11; 7.3%) and nausea or 
vomiting (n = 2; 1.3%). Some patients also showed 
increased aST levels (n = 27; 18.1%), and others 
showed both increased (n = 12; 12.08%) and decreased 
(n = 2; 1.34%) levels of aLT. The other disorders in 
these patients were both increased (n = 3; 2.01%) and 
decreased (n = 9; 6.04%) levels of albumin.
an et al. (2020) retrospectively investigated data of 
admitted patients with 2019-nCoV pneumonia from 
January 17 to 24, 2019, in Renmin Hospital of Wuhan, 
China. Of a total of nine patients enrolled in the study, 
all of them had only digestive symptoms with no fever 
at the onset. The main GI symptom was anorexia 
(66.7%), with other symptoms including nausea 
(11.1%), vomiting (11.1%), and diarrhea (11.1%). No 
patient reported abdominal pain. The median time for 
onset of digestive symptoms was 2.1 days. all nine 
patients were admitted to the hospital under isolation, 
and none of them was transferred to the ICU. as all of 
these patients presented with GI symptoms at the onset 
but without fever or other respiratory symptoms; con-
sideration of these atypical symptoms is very important 
to avoid missed diagnosis and prevent possible trans-
mission of COVID-19 infection.
Xia et al. (2020) retrospectively analyzed the clini-
cal and CT features of pediatric inpatients with 
COVID-19 infection from January 23 to February 8, 
2020, in Wuhan Children’s Hospital, China. They 
enrolled 20 pediatric patients in the study. Two of 
them were asymptomatic neonates with positive results 
from a pharyngeal swab COVID-19 nucleic acid test 
but negative CT findings. Fever (n = 12; 60%) and 
cough (n = 13; 65%) were the most common clinical 
manifestations among these patients. Diarrhea (n = 3; 
15%) and vomiting (n = 2; 10%) were the main GI 
manifestations. Liver dysfunction reflected as increased 
levels of aLT (>40 IU/L) occurred in five cases (25%).
Chang et al. (2020) investigated the epidemiological 
and clinical characteristics of COVID-19 infection in 
13 patients between January 16 and January 29, 2020, 
from three hospitals in Beijing, China. Two were chil-
dren. Twelve patients reported fever (mean = 1.6 
days) before hospitalization. Cough (n = 6; 46.2%), 
upper airway congestion (n = 8; 61.5%), myalgia (n = 
3; 23.1%), and headache (n = 3; 23.1%) were the 
most common symptoms. No patient required respira-
tory support before being transferred to the specialty 
hospital after a mean of 2 days. One presented with 
diarrhea as the main GI disorder (7.7%).
Xu, Wu, et al. (2020) investigated the clinical char-
acteristics of infected patients with SaRS-CoV-2 from 
January 10 to 26, 2020, in Zhejiang Province, China. 
among 62 patients in their study, fever (n = 48; 77%), 
cough (n = 50; 81%), expectoration (n = 35; 56%), 
and muscle pain (n = 32; 52%) were the most com-
mon symptoms. Diarrhea (n = 3; 8%) was the main GI 
symptom. Some patients presented higher levels of 
aST (n = 10; 16.1%).
Song et al. (2020) investigated noncontrast chest CT 
findings in patients with laboratory-confirmed 2019-
nCoV infection performed from January 20 to January 
27, 2020, at the Center for Disease Control, Shanghai, 
China. Of 51 patients enrolled in the study, fever 
(96%), cough (47%), and muscle pain (31%) were the 
most common symptoms. Diarrhea (n = 5; 10%), loss 
of appetite (n = 9; 18%), and nausea and vomiting (n 
= 3, 6%) were the main GI symptoms presenting in 
these patients.
Wang, Hu, et al. (2020) reported a case series of 
138 consecutive hospitalized patients with confirmed 
2019-nCoV-infected pneumonia at Zhongnan Hospital 
of Wuhan University, China, from January 1 to 28, 
2020. Of these, 26% of patients required admission to 
the ICU and 4.3% died. Fever (n = 136; 98.6%), dry 
cough (n = 82; 59.4%), and muscle pain (n = 96; 
69.6%) were the most common symptoms. The other 
common symptoms included lymphopenia (n = 97; 
70.3%), prolonged prothrombin time (n = 80; 58%), 
and elevated LDH (n = 55; 39.9%). anorexia (n = 55; 
39.9%), diarrhea (n = 14; 10.1%), nausea (n = 14; 
10.1%), and abdominal pain (n = 3; 2.2%) were the 
main GI symptoms among the patients. High levels of 
aLT, aST, and total bilirubin were observed in this 
population. Findings demonstrated that the patients 
with severe COVID-19 conditions (n = 36) showed a 
higher incidence of GI disorders than patients with 
mild conditions (n = 102).
Discussion
Disastrous consequences of COVID-19, as a new infec-
tious disease in humans, are rising sharply all over the 
world (Liu et al., 2020; Zhu et al., 2020). COVID-19 
presents extraordinary challenges for healthcare work-
ers (Carnero Contentti & Correa, 2020; Han et al., 
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2020; Zahidie, Iqbal, & Hussain, 2020). Respiratory 
symptoms are the most important manifestations of 
the disease, and human-to-human transmission is the 
main way for spread of the virus in the community set-
ting (Liu et al., 2020; Smargiassi et al., 2020). From 
February 21 to June 20, 2020, more than 89,000 cases 
have been diagnosed with COVID-19 in the authors’ 
country of Iran, with 6,150 deaths reported (Jahangiri, 
Jahangiri, & Najafgholipour, 2020; Nikpouraghdam 
et al., 2020; Shojaee et al., 2020). Staying at home or 
quarantining in an isolated center and minimizing 
going out are effective ways to battle the spread of 
COVID-19 (aminnejad & Hormati, 2020; Hormati, 
Ghadir, Foroghi Ghomi, et al., 2020; Hormati, Ghadir, 
Zamani, et al., 2020; Hormati, Niya, et al., 2020).
With the outbreak of COVID-19 infection starting 
in Wuhan, Hubei Province, China, patients were noted 
to exhibit various clinical symptoms. On the basis of 
these findings, we hypothesized that COVID-19 has a 
spectrum of symptoms, with GI symptoms among 
them. This review focuses on GI symptoms of 
COVID-19 in China beginning after the first report of 
this infection there.
after infection with COVID-19, patients may pre-
sent various spectrum of symptoms (Baj et al., 2020; 
Xu, Li, Tian, Li, & Kong, 2020). It is well documented 
that respiratory symptoms are the main characteristic 
features of COVID-19, occurring in the majority of 
patients with cough and fever (Xu, Wu, et al., 2020). 
although not the primary symptom, it is well docu-
mented that GI symptoms are also consistently mani-
fested with the disease (Redd et al., 2020; Tian, Rong, 
Nian, & He, 2020). The main GI complaints include 
anorexia, diarrhea, vomiting, nausea, abdominal pain, 
hepatic involvement, and GI bleeding (Hormati et al., 
2021; Hormati, Shahhamzeh, afifian, Khodadust, & 
ahmadpour, 2020; Musa, 2020; Redd et al., 2020).
Diarrhea is the most common GI symptom reported 
and may be considered as an initial symptom in some 
infected patients (D’amico, Baumgart, Danese, & 
Peyrin-Biroulet, 2020; yang, Zhao, et al., 2020). In 
comparison with adults in whom decreased appetite is 
prominent, vomiting is more prominent in children. 
Huang et al. (2020) first reported the clinical GI symp-
toms of COVID-19, noting that only 3% of their 
patients had diarrhea (Huang et al., 2020). We previ-
ously reported that patients with SaRS-CoV-2 infection 
can present unusual or pure GI symptoms in the absence 
of respiratory symptoms (Hormati, Shahhamzeh, 
afifian, et al., 2020; Hormati, Shahhamzeh, aminnejad, 
afifian, & ahmadpou, 2020). In some patients, GI 
symptoms (e.g., diarrhea) did not occur due to infection 
with COVID-19, and other reasons such as the side 
effects of medications are the likely cause for this symp-
tom (Hu et al., 2020).
according to the incidence of some GI symptoms in 
patients with COVID-19 globally, the authors’ country is 
no exception. after the first outbreak of COVID-19 in 
Qom City, Iran, the number of patients referred to our GI 
clinics increased by 20% (Hormati, Ghadir, Zamani, et al., 
2020; Hormati, Shahhamzeh, afifian, 2020; Hormati, 
Shahhamzeh, aminnejad, et al., 2020). The incidence of 
GI complications during COVID-19 is unexpected, and 
most of these GI symptoms are resistant to medications. 
Diarrhea and anorexia were the most common GI symp-
toms in patients who visited our GI clinic. The incidence of 
other GI symptoms is less common and includes nausea, 
vomiting, and hemorrhage. GI bleeding and abdominal 
pain were more frequent in severely ill patients. We also 
noticed the incidence of some rare GI symptoms such as 
hyperbilirubinemia, upper GI bleeding, and dysentery 
(Hormati et al., 2021). We noticed that the incidence of GI 
manifestations was higher in the later stage than in the 
early stage of the COVID-19 pandemic, and the propor-
tion of GI symptoms in severely affected patients was 
higher than that in nonsevere patients. Most patients had 
no respiratory symptoms at the time of referral to our GI 
clinic and some had GI symptoms (Hormati, Shahhamzeh, 
afifian, et al., 2020). Because these patients were unaware 
of their COVID-19 infection, these patients were carriers 
of the disease during the onset of their GI symptoms.
During COVID-19, awareness and diagnosis of the 
incidence of GI symptoms have an inestimable impor-
tance, as timely diagnosis can play a significant role in 
controlling the spread of the virus. Because COVID-19 is 
still new and its complications are increasing day by day, 
in some cases, we find no suitable justification for some 
GI symptoms. On the basis of this, we relied on other 
diagnostic methods, such as endoscopy and colonosco-
py, to ensure and distinguish the symptoms of the disease 
from other diseases such as inflammatory bowel diseases 
or cancer. Because performing these procedures requires 
a close proximity between the endoscopist, the nurse(s), 
and the infected patient, the possibility of infection in 
our clinic personnel is increased (almadi et al., 2020). as 
a result, we have attentively used recommended infection 
control approaches to protect the health of our GI team 
during risky procedures (Hormati, Ghadir, Zamani, et al., 
2020; Hormati, Niya, et al., 2020).
Conclusion
We have previously reported that reducing close con-
tact is the only effective way to fight the COVID-19 
virus (Hormati, Ghadir, Foroghi Ghomi, et al., 
2020). as a result, we have attempted to conduct 
most of our clinical visits virtually and reserve high-
risk diagnostic methods only for emergencies. Over 
time, another new range of symptoms may emerge 
with COVID-19, some of which may be related to 
the GI tract. Based on our analysis of the initial 
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Ciesielka, M., Sitarz, E., … Maciejewski, R. (2020). COVID-19: 
specific and non-specific clinical manifestations and symptoms: 
The current state of knowledge. Journal of Clinical Medicine, 
9(6), 1753.
Carnero Contentti, E., & Correa, J. (2020). Immunosuppression 
during the COVID-19 pandemic in neuromyelitis optica spec-
trum disorders patients: a new challenge. Multiple Sclerosis and 
Related Disorders, 41, 102097.
Chang, D., Lin, M., Wei, L., Xie, L., Zhu, G., Dela Cruz, C. S.,  … 
Sharma, L. (2020). Epidemiologic and clinical characteristics of 
novel coronavirus infections involving 13 patients outside Wu-
han, China. JAMA, 323(11), 1092–1093.
Chen, J., Qi, T., Liu, L., Ling, y., Qian, Z., Li, T.,  … Lu, H. (2020). 
Clinical progression of patients with COVID-19 in Shanghai, 
China. Journal of Infection, 80(5), e1–e6.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, y.,  … Zhang, 
L. (2020). Epidemiological and clinical characteristics of 99 cas-
es of 2019 novel coronavirus pneumonia in Wuhan, China: a 
descriptive study. The Lancet, 395(10223), 507–513.
D’amico, F., Baumgart, D. C., Danese, S., & Peyrin-Biroulet, L. 
(2020). Diarrhea during COVID-19 infection: Pathogenesis, epi-
demiology, prevention and management. Clinical Gastroenterol-
ogy and Hepatology, 18(8), 1663–1672.
Fang, D., Ma, J., Guan, J., Wang, M., Song, y., Tian, D., & Li, 
P. (2020). Manifestations of digestive system in hospitalized 
patients with novel coronavirus pneumonia in Wuhan, China: 
a single-center, descriptive study. Chinese Journal of Digestive 
Diseases, (12), E005–E005.
Gao, Q. y., Chen, y. X., & Fang, J. y. (2020). 2019 Novel coro-
navirus infection and gastrointestinal tract. Journal of Digestive 
Diseases,  21(3), 125–126.
Ghinai, I., McPherson, T. D., Hunter, J. C., Kirking, H. L., Chris-
tiansen, D., Joshi, K., … Layden, J. E.; Illinois COVID-19 
Investigation Team. (2020). First known person-to-person 
studies emerging from China, particularly related to 
the manifestation of GI complaints, careful examina-
tion and recording of these symptoms can be a way 
to identify the disease and the pathogenic infectious 
mechanism of this mysterious disease. ✪
Copyright © 2021 Society of Gastroenterology Nurses and Associates. Unauthorized reproduction of this article is prohibited.
Gastrointestinal Symptoms in COVID-19 Patients
VOLUME 44  |  NUMBER 1  |  JaNUaRy/FEBRUaRy 2021 E9
Huang, C., Wang, y., Li, X., Ren, L., Zhao, J., Hu, y.,  … Cao, 
B. (2020). Clinical features of patients infected with 2019 
novel coronavirus in Wuhan, China. The Lancet, 395(10223), 
497–506.
Jahangiri, M., Jahangiri, M., & Najafgholipour, M. (2020). The 
sensitivity and specificity analyses of ambient temperature and 
population size on the transmission rate of the novel coronavirus 
(COVID-19) in different provinces of Iran. The Science of the 
Total Environment, 728, 138872.
Liang, W., Feng, Z., Rao, S., Xiao, C., Xue, X., Lin, Z. … Qi, W. 
(2020). Diarrhoea may be underestimated: a missing link in 
2019 novel coronavirus. Gut, 69(6), 1141–1143.
Li, X., Xu, S., yu, M., Wang, K., Tao, y., Zhou, y.,  … Zhao, J. 
(2020). Risk factors for severity and mortality in adult COV-
ID-19 inpatients in Wuhan. Journal of Allergy and Clinical Im-
munology, 146(1), 110–118.
Liu, W., Zhang, Q., Chen, J., Xiang, R., Song, H., Shu, S.,  … Liu, 
y. (2020). Detection of COVID-19 in children in early January 
2020 in Wuhan, China. The New England Journal of Medicine, 
382(14), 1370–1371.
Meng, H., Xiong, R., He, R., Lin, W., Hao, B, Zhang, L.,  … Geng, 
Q. (2020). CT imaging and clinical course of asymptomatic cas-
es with COVID19 pneumonia at admission in Wuhan, China. 
Journal of Infection, 81(1), e33–e39.
Musa, S. (2020). Hepatic and gastrointestinal involvement in coro-
navirus disease 2019 (COVID-19): What do we know till now? 
Arab Journal of Gastroenterology, 21(1), 3–8.
Nikpouraghdam, M., Jalali Farahani, a., alishiri, G., Heydari, S., 
Ebrahimnia, M., Samadinia, H., … Bagheri, M. (2020). Epide-
miological characteristics of coronavirus disease 2019 (COV-
ID-19) patients in IRaN: a single center study. Journal of Clini-
cal Virology, 127, 104378.
Redd, W. D., Zhou, J. C, Hathorn, K. E., McCarty, T. R., Bazarbashi, 
a. N., Thompson, C. C.,  … Chan, W. W. (2020). Prevalence 
and characteristics of gastrointestinal symptoms in patients with 
SaRS-CoV-2 infection in the United States: a multicenter cohort 
study. Gastroenterology, 159(2), 765–767.e2.
Shojaee, S., Pourhoseingholi, M. a., ashtari, S., Vahedian-azimi, a., 
asadzadeh-aghdaei, H., & Zali, M. R. (2020). Predicting the 
mortality due to COVID-19 by the next month for Italy, Iran 
and South Korea; a simulation study. Gastroenterology and 
Hepatology from Bed to Bench, 13(2), 177–179.
Smargiassi, a., Soldati, G., Borghetti, a., Scoppettuolo, G., Tam-
burrini, E., Testa, a.C., Moro, F., Natale, L., Larici, a.R., Buon-
senso, D. and Valentini, P., 2020. Lung ultrasonography for 
early management of patients with respiratory symptoms dur-
ing COVID-19 pandemic. Journal of Ultrasound, 07 Jul 2020, 
23(4):449-456. DOI: 10.1007/s40477-020-00501-7 PMID: 
32638333 PMCID: PMC7338342.
Sohrabi, C., alsafi, Z., O’Neill, N., Khan, M., Kerwan, a., al-Jabir, 
a.,  … agha, R. (2020). World Health Organization declares 
global emergency: a review of the 2019 novel coronavirus 
(COVID-19). International Journal of Surgery, 76, 71–76.
Song, F., Shi, N., Shan, F., Zhang, Z., Shen, J., Lu, H.,  … Shi, y. 
(2020). Emerging 2019 novel coronavirus (2019-nCoV) pneu-
monia. Radiology, 295(1), 210–217.
Tian, y., Rong, L., Nian, W, & He, y. (2020). Review article: Gastroin-
testinal features in COVID-19 and the possibility of faecal transmis-
sion. Alimentary Pharmacology & Therapeutics, 51(9), 843–851.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., … Peng, Z. 
(2020). Clinical characteristics of 138 hospitalized patients with 
2019 novel coronavirus-infected pneumonia in Wuhan, China. 
JAMA, 323(11), 1061–1069.
Wang, X., Fang, J., Zhu, y., Chen, L., Ding, F., Zhou, R.,  … Zhao, Q. 
(2020). Clinical characteristics of non-critically ill patients with 
novel coronavirus infection (COVID-19) in a Fangcang Hospital. 
Clinical Microbiology and Infection, 26(8), 1063–1068.
World Health Organization. (2020a). Coronavirus disease (COVID- 
2019) situation reports. Retrieved from https://www.WHO.Int/
docs/defaultsource/coronaviruse/situationreports/20200221-
sitrep-32-covid19
World Health Organization. (2020b). Modes of transmission of virus 
causing COVID-19: Implications for IPC precaution recommenda-
tions: Scientific brief, 27 March 2020. Geneva, Switzerland: author.
Wu, J., Liu, J., Zhao, X., Liu, C., Wang, W., Wang, D.,  … Li, L. 
(2020). Clinical characteristics of imported cases of corona-
virus disease 2019 (COVID-19) in Jiangsu Province: a multi-
center descriptive study. Clinical Infectious Diseases, 71(15), 
706–712.
Xia, W., Shao, J., Guo, y., Peng, X., Li, Z., & Hu, D. (2020). 
Clinical and CT features in pediatric patients with COVID-19 
infection: Different points from adults. Pediatric Pulmonol-
ogy,55(5), 1169–1174.
Xu, X. W., Wu, X. X., Jiang, X. G., Xu, K. J., ying, L. J., Ma, C. 
L.,  … Li, L. J. (2020). Clinical findings in a group of patients 
infected with the 2019 novel coronavirus (SaRS-Cov-2) outside 
of Wuhan, China: Retrospective case series. BMJ (Clinical Re-
search Ed.), 368, m606.
Xu, Z., Li, S., Tian, S., Li, H., & Kong, L. Q. (2020). Full spec-
trum of COVID-19 severity still being depicted. The Lancet, 
395(10228), 947–948.
yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, a.,  … yan, 
F. (2020). Clinical characteristics and imaging manifestations of 
the 2019 novel coronavirus disease (COVID-19): a multi-center 
study in Wenzhou city, Zhejiang, China. Journal of Infection, 
80(4), 388–393.
yang, X., Zhao, J., yan, Q., Zhang, S., Wang, y., & Li, y. (2020). a 
case of COVID-19 patient with the diarrhea as initial symptom 
and literature review. Clinics and Research in Hepatology and 
Gastroenterology, 44(5), e109–e112.
yeo, C., Kaushal, S., & yeo, D. (2020). Enteric involvement of 
coronaviruses: Is faecal-oral transmission of SaRS-CoV-2 
possible? The Lancet Gastroenterology & Hepatology, 5(4), 
335–337.
ye, J., Zhang, B., Xu, J., Chang, Q., McNutt, M. a., Korteweg, C., 
… Gu, J. (2007). Molecular pathology in the lungs of severe 
acute respiratory syndrome patients. American Journal of Pa-
thology, 170(2), 538–545.
yu, P., Zhu, J., Zhang, Z., & Han, y. (2020). a familial cluster 
of infection associated with the 2019 novel coronavirus in-
dicating potential person-to-person transmission during the 
incubation period. Journal of Infectious Diseases, 221(11), 
1757–1761.
Zahidie, a., Iqbal, M., & Hussain, S. W. (2020). Worsening of the 
COVID-19 Pandemic in New york City: analysis of response 
gaps and challenges at the public policy and community levels. 
Journal of the College of Physicians and Surgeons Pakistan, 
30(6), 32–36. 
Copyright © 2021 Society of Gastroenterology Nurses and Associates. Unauthorized reproduction of this article is prohibited.
Gastrointestinal Symptoms in COVID-19 Patients
E10 Copyright © 2021 Society of Gastroenterology Nurses and associates Gastroenterology Nursing
Zarifian, a., Bidary, Z. M., arekhi, S., Rafiee, M., Gholamalizadeh, 
H., amiriani, a., ... Ganji a. (2020). Gastrointestinal and he-
patic abnormalities in patients with confirmed COVID-19: a 
systematic review and meta-analysis. Journal of Medical Virol-
ogy. advance online publication. doi: 10.1002/jmv.26314
Zhang, L., Zhu, F., Xie, L., Wang, C., Wang, J., Chen, R.,  … Zhou, 
M. (2020). Clinical characteristics of COVID-19-infected cancer 
patients: a retrospective case study in three hospitals within Wu-
han, China. Annals of Oncology, 31(7), 894–901.
Zhu, N., Zhang, D., Wang, W., Li, X., yang, B., Song, J., ... Tan, 
W.; China Novel Coronavirus Investigating and Research 
Team. (2020). a novel coronavirus from patients with pneu-
monia in China, 2019. The New England Journal of Medicine, 
382(8):727–733.
Copyright © 2021 Society of Gastroenterology Nurses and Associates. Unauthorized reproduction of this article is prohibited.
